Skip to content
LongevityGraded

Review

Breeze Meds Review: Three NAD+ Prices on One Page

Breeze Meds sells NAD+ at $169, $179 and $249 on the same page — and publishes no terms of service or refund policy at all.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page
B

Featured partner

Grade B

CoreAge Rx

Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.

$93–$99/mo (starting rates)

We may earn a commission through this link, at no extra cost to you.

Check availability
Pricing
Varies by plan
Pharmacy
503A compounding pharmacy
Labs
Depends on treatment
Consult
Clinician review included
Support
Human support included

Grades come from each provider's published terms. How we're funded

A

Partner

Grade A

Embody

One flat $99 a month for NAD+ in either format, with the pharmacy named — and a dose range of 500 to 1000mg behind the single price.

$99/mo flat, either format

We may earn a commission through this link, at no extra cost to you.

Visit Embody

The $99 is a "LIMITED FALL SALE" rate against an implied $199, and the sale has no published end date. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.

The one-sentence version

Breeze Meds has quietly become a longevity provider — NAD+ by injection and by nasal spray, plus sermorelin, on top of the compounded GLP-1 line it started with — and it bundles more into the monthly figure than most providers here: the medical consultation, unlimited consultations afterwards, secure messaging and 24/7 support, all stated as included. Then the page that sells NAD+ carries three different prices for it, its sermorelin card disagrees with its own catalog by $35, and the site publishes no terms of service, no refund policy and no cancellation policy at all. It grades B, 9 points out of 14, computed from its published terms alone.

What it is, and what it sells

The operating entity is Breezemeds, LLC, described in its own inline privacy policy as "a Delaware corporation" at 134 South Avenue SE, Marietta GA 30060 — although the consultation footer says Breezemeds, Inc. The platform underneath is CareValidate, the same white-label backend behind Care Bare Rx, Synergy Rx and several others, which means its clinicians, pharmacies and FAQ language are shared property rather than independent corroboration of anyone else's.

The catalog is short and current:

One page, several answers

NAD+ injection$169/mo$169/mo"$179 to start" (hero) · "$249/month" regular (FAQ)
NAD+ nasal spray$210/mo$210/moNo competing figure
Sermorelin injection$100$135/moNo competing figure
From Breeze Meds' own NAD+ page and its catalog. The card and the catalog agree on $169 and $210; the same page's hero and FAQ do not.

Beside it: compounded semaglutide injection at $199 a month, tirzepatide injection at $299, oral semaglutide at $299 and oral tirzepatide at $399. No glutathione, no B-12, no methylene blue, no other growth-hormone peptides, no TRT or HRT, no supplements.

Four numbers, one product, one page

Here is what Breeze's NAD+ page says about NAD+, in the order you meet it:

  • the hero: *"Just $179 to start"*
  • a product card: *"Starting at $169 — NAD+ Injection"*
  • another card: *"Starting at $210 — NAD+ Nasal Spray"*
  • and the FAQ, at the bottom of the same page: *"BreezeMeds NAD+ therapy starts regular at just $249/month, including your medical consultation, prescription, medication, and free shipping."*

Three of those are for the injection. $179, $169 and $249. The card and the catalog behind the page both say $169, which is why $169 is the figure this review publishes — but Breeze's own FAQ calls $249 the regular monthly rate, which is precisely the number a buyer needs and precisely the one that contradicts the card.

The sermorelin line does the same thing on a smaller scale: the card says $100, the catalog behind the same page says $135.

Why that zeroes the price factor. Our rubric asks for a figure — singular — that a buyer can rely on before committing. Two of four numbers agreeing is not that. This is not the familiar trap where an advertised rate turns out to be a twelve-month prepay; there is no term hiding behind any of these figures. It is simpler and stranger: the page has not been reconciled with itself. Compare System Labs, which also prints two numbers per product — but prints them as a struck-through pair, first month against standing rate, so the relationship between them is legible. It keeps all four points. Breeze prints three numbers with no relationship stated at all.

And the bundles are worse than monthly. The three-month semaglutide bundle is $748, which is $249.33 a month against $199 month-to-month. Do not read the multi-month rungs as savings.

One charge that is not in any headline: an $80 consultation fee if you choose a phone or video visit and then do not proceed.

What it does publish, and it is more than you would expect

The monthly figure genuinely includes the consultation. Breeze's own FAQ says so — "including your medical consultation, prescription, medication, and free shipping" — and its NAD+ page goes further: "Unlimited 24/7 Support, Included. BreezeMeds connects you with our dedicated team of NAD+ specialists… With unlimited consultations, secure messaging, and expert guidance." That is a statement about what the price buys, which is what our oversight and support factors ask for, and Breeze takes all four of those points.

Four dispensing pharmacies are named with phone numbers on its homepage — Belmar Pharmacy, Strive Pharmacy, Epiq Scripts and Casa Pharma Rx — alongside the clinical group Lion MD and two prescribing physicians with NPI numbers, Dr. Ana Lisa Carr, MD (1689841744) and Dr. Kelly Tenbrink, MD (1346482684). What it never does is classify any of them: the strings "503A" and "503B" appear nowhere on the site, so Breeze takes the middle rung of our pharmacy ladder — one point of two — for naming without classifying.

Belmar, in proportion. One of the four, Belmar, received an FDA warning letter issued 31 March 2023, addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy", and FDA closed it out on 30 October 2023. We do not restate what it alleged; the searchable index is cited below1 and it is FDA's document to characterize. The letter is closed out, and any page that leaves that off is publishing a false impression. Breeze Meds itself holds no FDA warning letter in FDA's public index. And note the direction of the trade: you can only weigh Belmar at all because Breeze names its pharmacies, which most providers here decline to do.

States: its FAQ says "We service all 50 states." No exclusion list is published against that anywhere on the site.

The paperwork that does not exist

This is the part that would give a careful buyer pause, and it has nothing to do with prices.

Breeze Meds publishes no terms of service. There is no published refund policy and no published cancellation policy anywhere on the site, and its privacy policy exists only as text on the homepage — so what happens if a clinician declines you, if you cancel before the pharmacy fills, or if a shipment goes wrong is simply not written down. Every other provider here that we have criticized for a harsh refund policy at least has one.

Its own claims disagree with each other. The homepage says "50,000+" patients; its NAD+ page says "100,000+". And the NAD+ page publishes efficacy figures — "9/10 patients report feeling 10 years younger" — attributed only to customer surveys, with no methodology, sample or date. Treat those as marketing, not evidence.

The evidence behind what it sells

This ranking grades providers, not molecules, but $169 a month is about $2,000 a year and the state of the evidence belongs in the decision.

NAD+ precursors reliably raise NAD+ levels in the blood, but better energy, strength or health in healthy adults has not followed, and the two routes Breeze sells, injection and nasal spray, have the least human outcome evidence of all. What the research does and does not show is in NAD+ for longevity and NAD+ injections vs IV vs oral.

Sermorelin raises your own growth hormone, and raising growth hormone in healthy older adults has not been shown to improve how they function, while side effects go up. See sermorelin for longevity. Compounded NAD+ and sermorelin are not FDA-approved, and FDA's own position is that compounded drugs are not FDA-approved and it does not verify their safety, effectiveness or quality before marketing2. Set that beside the "9/10 patients report feeling 10 years younger" claim and you have the whole reason we grade the evidence separately from the provider.

Before you start

Five things to settle before you pay Breeze Meds

  • Ask in writing: is the ongoing NAD+ rate $169 or $249? The card and catalog say $169; the same page's FAQ calls $249 the regular monthly rate.
  • Ask the same about sermorelin. The card says $100, the catalog behind the page says $135.
  • There is no refund or cancellation policy to read — Breeze publishes no terms of service at all.
  • The multi-month bundles are not savings — three months of semaglutide at $748 is $249.33/mo against $199 month-to-month.
  • Budget the $80 consultation fee if you pick a phone or video visit and then do not proceed.

Where it's weak, and who should skip it

Skip it if you need to know what month two costs, because Breeze's own page gives you three answers and its FAQ calls the highest of them the regular rate. Skip it if you want a written refund or cancellation policy, because there is not one — not a harsh one, none at all. And skip the multi-month bundles regardless: they cost more per month than paying monthly.

Buy it if you want two NAD+ routes with the consultation, unlimited follow-up consultations, messaging and 24/7 support genuinely inside one monthly figure, from a provider that names four pharmacies and two physicians — and you are willing to get the actual monthly number confirmed in writing before your card is charged. Ask specifically: is the ongoing rate $169 or $249?

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Breeze takes the full four for its longevity line — NAD+ in two routes plus sermorelin is exactly what this site ranks — two for clinical oversight, because the consultation is stated as inside the price, two for support, on published unlimited consultations and 24/7 messaging, and one of two for pharmacy, for naming four facilities without classifying them. It takes zero for price transparency, because one page carries three prices for one product. Nine out of fourteen: a B.

The fix is smaller than the criticism sounds: reconcile one page to one number, print the sermorelin figure the catalog actually holds, and publish a terms of service with a refund policy in it. Do that and Breeze is a thirteen-point A without changing anything about the medicine or the price. Until then the review's practical advice is the same as its criticism — get the number in writing. The full graded field is at our provider rankings, the scoring is in how we grade, and what this category costs generally is in longevity clinic cost.

Compare Breeze Meds with

We may earn a commission through these links, at no extra cost to you. Disclosure

A

Partner

bmiMD $159/mo NAD+ · $139/mo sermorelin

Visit bmiMD

See every graded provider ↗

Frequently asked questions

How much does Breeze Meds NAD+ cost?

$169 a month for the injection and $210 a month for the nasal spray — those are the figures on Breeze's own product cards and in the catalog behind that page, which agree with each other. The reason this needs a longer answer is that the same page carries two other numbers for the injection: the hero says "Just $179 to start", and the FAQ at the bottom says "BreezeMeds NAD+ therapy starts regular at just $249/month, including your medical consultation, prescription, medication, and free shipping." Three figures, one product, one page, with no stated relationship between them. Sermorelin has a smaller version of the same problem: the card says $100 and the catalog says $135. Everything is month-to-month with no prepay term required. The practical advice is to get the ongoing monthly rate confirmed in writing before your card is charged, and to ask specifically whether $249 applies after any introductory period.

Does Breeze Meds have a refund policy?

No — and this is an absence rather than a harsh policy. There is no terms of service, no refund policy and no cancellation policy published anywhere on Breeze's site; the privacy policy exists only as text on the homepage. So what happens if a clinician declines you, if you cancel before the pharmacy fills your prescription, or if a shipment is lost is simply not written down anywhere you can read it before paying. Several providers here publish refund terms we criticize for being strict; Breeze publishes none to criticize. If you buy here, get the cancellation and refund terms in writing from support before your first charge, and keep the reply.

Is Breeze Meds legit?

It transacts, it is certified, and it names the people involved — with some loose ends around the edges. The operating entity is Breezemeds, LLC of 134 South Avenue SE, Marietta GA 30060, though its own consultation footer says Breezemeds, Inc., and the privacy policy calls the LLC "a Delaware corporation". It publishes a LegitScript Healthcare Merchant Certified badge under seal ID 47653984. It names four dispensing pharmacies with phone numbers — Belmar, Strive, Epiq Scripts and Casa Pharma Rx — and two prescribing physicians with NPI numbers, Dr. Ana Lisa Carr, MD (1689841744) and Dr. Kelly Tenbrink, MD (1346482684). Breeze Meds itself holds no FDA warning letter in FDA's public index. It runs on the CareValidate platform, so its clinicians and pharmacies are shared with several sibling brands rather than being independent corroboration of any of them. It grades B at 9 out of 14, and the deductions are about what its pages say rather than about whether the company is real.

One of Breeze's pharmacies had an FDA warning letter — does that matter?

As a disclosure, yes; as a disqualification, no — and the closure date is the part that usually goes missing. Belmar, one of the four pharmacies Breeze names, received an FDA warning letter issued 31 March 2023, addressed to "Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy", and FDA closed it out on 30 October 2023. We do not restate the allegations here; that is FDA's document to characterize, and the searchable index is cited on this page. Two things follow. The letter is closed out, so describing it as an open action would publish a false impression. And you can only weigh it at all because Breeze names its pharmacies — the providers here that name none could be dispensing through anyone, and there would be nothing to check. Breeze Meds itself has no warning letter against it.

Are Breeze Meds' multi-month bundles cheaper?

No, and that is worth checking rather than assuming. Breeze's compounded semaglutide is $199 a month month-to-month, while its three-month bundle costs $748 — which works out at $249.33 a month, about 25% more than simply paying monthly. The six- and twelve-month bundles at $1,248 and $2,298 run to $208 and $191.50 a month respectively, so only the longest terms beat the monthly rate at all. Tirzepatide follows the same shape from a $299 monthly base. The general rule here is that a multi-month figure is usually a discount disguised as a monthly price; here it is the reverse, and a buyer who assumes a bundle must be cheaper pays more for a longer commitment. On the NAD+ and sermorelin line no multi-month rungs are published at all.

Why does Breeze Meds grade B rather than A?

It drops four points in one place and one in another. Price transparency, which our rubric weights double, scores zero: the factor asks for a single figure a buyer can rely on before committing, and Breeze's own NAD+ page carries three — $179 in the hero, $169 on the card, and an FAQ calling $249 the regular monthly rate — with the sermorelin card and catalog disagreeing by another $35. It also loses one of two pharmacy points, for naming four dispensing facilities without classifying any as 503A or 503B. Everything else scores full marks: four for a genuine longevity line, since NAD+ by injection and nasal spray plus sermorelin is exactly what this site ranks; two for clinical oversight, since the medical consultation is stated as inside the monthly figure; and two for human support, on published unlimited consultations, secure messaging and 24/7 access. That is 9 out of 14. Reconciling one page to one number would make it 13 and an A — the missing terms of service, which we regard as the more serious problem, is not something this rubric has a factor for, which is why it is written up above rather than buried in a score.

References

  1. U.S. Food and Drug Administration (2026). Warning Letters (searchable index of FDA warning letters, with issue and close-out dates). FDA — Compliance Actions and Activities.
  2. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.